62106-9019 : Taraxacum Officinale 1 [hp_x]/1 Oral Granule


NDC62106-9019
Labeler: Seroyal USA
Product Type: Human OTC Drug
Drug Name: Taraxacum Officinale
Dosage Form: Oral Granule
Rev. Date: 


NDC Package Codes:

  • 62106-9019-4: 10 TUBE IN 1 CARTON (62106‑9019‑4) > 140 GRANULE IN 1 TUBE

Active Ingredients:

  • Taraxacum Officinale

Dosage Strength:

  • 1 [hp_X]/1

Related Products:

Based on records with the same trade name.
  • 0220-4933 Taraxacum Officinale 6 [Hp_c]/6[hp_c] Oral Pellet by Boiron
  • 0220-4934 Taraxacum Officinale 30 [Hp_c]/30[hp_c] Oral Pellet by Boiron
  • 37662-1293 Taraxacum Officinale 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1294 Taraxacum Officinale 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1295 Taraxacum Officinale 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1296 Taraxacum Officinale 100 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1297 Taraxacum Officinale 200 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1298 Taraxacum Officinale 500 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1299 Taraxacum Officinale 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-1300 Taraxacum Officinale 1 [Hp_q]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 68428-663 Taraxacum Officinale 30 [Hp_c]/1 Oral Pellet by Washington Homeopathic Products
  • 71919-665 Taraxacum Officinale 30 [Hp_c]/Ml Oral Liquid by Washington Homeopathic Products

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 62106-9019 QR Code

< Prev: 62106-9003Next: 62106-9052 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.